Bayer AG has proposed a $7.25 billion settlement to address thousands of lawsuits in the United States alleging that its herbicide, Roundup, causes non-Hodgkin’s lymphoma. This proposal, filed in the St. Louis Circuit Court in Missouri, aims to resolve both current and future claims from individuals exposed to Roundup before the settlement date. The agreement outlines annual payments into a special fund over a period of up to 21 years, with compensation amounts varying based on factors such as the claimant’s age, level of exposure, and severity of illness. For instance, agricultural workers under 60 diagnosed with aggressive forms of the disease could receive an average of $165,000, while older residential users with less severe diagnoses might receive around $20,000. ([apnews.com](https://apnews.com/article/154ad7c6bdff3a91b06c4e327321160b?utm_source=openai))
The legal community has offered mixed reactions to the proposed settlement. Some attorneys view it as a significant step toward resolving the extensive litigation surrounding Roundup. Bayer’s CEO, Bill Anderson, emphasized the company’s desire to “end the litigation uncertainty” through this agreement. ([findlaw.com](https://www.findlaw.com/legalblogs/courtside/proposed-7-25-billion-settlement-for-bayers-roundup-cases-might-not-be-the-end-of-the-road/?utm_source=openai))
However, other legal professionals have raised concerns about the adequacy of the compensation. Attorney Matt Clement, representing approximately 280 plaintiffs, expressed surprise at the settlement terms and anticipates that many of his clients will opt out, describing the proposed payouts as “exceedingly too small.” ([apnews.com](https://apnews.com/article/154ad7c6bdff3a91b06c4e327321160b?utm_source=openai))
This settlement proposal comes at a critical juncture, as the U.S. Supreme Court is set to hear arguments on whether federal pesticide labeling laws preempt state failure-to-warn claims. A ruling in favor of Bayer could potentially limit future lawsuits, but the proposed settlement seeks to mitigate risks regardless of the Court’s decision. ([findlaw.com](https://www.findlaw.com/legalblogs/courtside/proposed-7-25-billion-settlement-for-bayers-roundup-cases-might-not-be-the-end-of-the-road/?utm_source=openai))
Despite the proposed settlement, Bayer continues to deny any liability or wrongdoing, maintaining that glyphosate, Roundup’s active ingredient, is safe for use. The company has also ceased using glyphosate in Roundup products sold for residential lawn and garden use in the U.S., though it remains in agricultural formulations. ([apnews.com](https://apnews.com/article/154ad7c6bdff3a91b06c4e327321160b?utm_source=openai))
As the legal proceedings unfold, the proposed settlement represents a pivotal moment in the ongoing litigation over Roundup. The court’s approval and the response from plaintiffs will ultimately determine the settlement’s effectiveness in resolving these longstanding disputes.